Silverarc Capital Management, LLC Celldex Therapeutics, Inc. Transaction History

Silverarc Capital Management, LLC

$402 Million
Q3 2024

A detailed history of Silverarc Capital Management, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 145,000 shares of CLDX stock, worth $3.8 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares

145,000

Previous 374,910 61.32%

Holding current value

$3.8 Million

Previous $13.9 Million 64.5%

% of portfolio

1.23%

Previous 3.94%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$32.06 - $44.56 $7.37 Million - $10.2 Million	-229,910 Reduced 61.32%	145,000 $4.93 Million
Q2 2024 Aug 14, 2024	BUY	$32.76 - $42.56 $2.48 Million - $3.22 Million	75,594 Added 25.26%	374,910 $13.9 Million
Q1 2024 May 14, 2024	BUY	$35.22 - $51.88 $1.83 Million - $2.7 Million	52,101 Added 21.08%	299,316 $12.6 Million
Q4 2023 Feb 14, 2024	BUY	$22.61 - $40.65 $5.59 Million - $10 Million	247,215 New	247,215 $9.8 Million
Q2 2023 Aug 14, 2023	SELL	$30.29 - $38.28 $2.26 Million - $2.86 Million	-74,651 Reduced 88.19%	10,000 $339,000
Q1 2023 May 15, 2023	BUY	$34.78 - $47.43 $1.04 Million - $1.42 Million	29,952 Added 54.76%	84,651 $3.05 Million
Q4 2022 Feb 14, 2023	BUY	$27.78 - $45.38 $39,558 - $64,621	1,424 Added 2.67%	54,699 $2.44 Million
Q3 2022 Oct 28, 2022	BUY	$22.7 - $37.57 $384,833 - $636,924	16,953 Added 46.67%	53,275 $1.5 Million
Q2 2022 Jul 25, 2022	SELL	$20.5 - $37.33 $188,928 - $344,033	-9,216 Reduced 20.24%	36,322 $979,000
Q1 2022 May 13, 2022	BUY	$27.64 - $39.32 $11,221 - $15,963	406 Added 0.9%	45,538 $256,000
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $245,799 - $387,644	6,889 Added 18.01%	45,132 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $819,921 - $1.59 Million	28,322 Added 285.48%	38,243 $2.07 Million
Q2 2021 Aug 16, 2021	BUY	$20.71 - $35.37 $205,463 - $350,905	9,921 New	9,921 $2.93 Million
Q1 2021 May 18, 2021	SELL	$16.19 - $29.91 $1.3 Million - $2.4 Million	-80,282 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.99 - $22.75 $1.2 Million - $1.83 Million	80,282 New	80,282 $1.41 Million

Others Institutions Holding CLDX

# of Institutions

207

Shares Held

67.3M

Call Options Held

1.69M

Put Options Held

980K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.23B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Celldex Therapeutics, Inc. Transaction History